Wed, February 11, 2009
[ Wed, Feb 11th 2009 ] - Market Wire
Oscient Pharmaceuticals Restructures Commercial Organization
[ Wed, Feb 11th 2009 ] - Market Wire
Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan
[ Wed, Feb 11th 2009 ] - Market Wire
ZymoGenetics Reports Fourth Quarter and Year End 2008 Financial Results
[ Wed, Feb 11th 2009 ] - Market Wire
Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus
[ Wed, Feb 11th 2009 ] - Market Wire
Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009
[ Wed, Feb 11th 2009 ] - Market Wire
ImmuCell Corporation: ImmuCell Announces Financial Results for 2008
[ Wed, Feb 11th 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ
[ Wed, Feb 11th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics Announces Major Shipments
[ Wed, Feb 11th 2009 ] - Market Wire
Lpath, Inc.: Category Leader Lpath Establishes Key 2009 Goals
[ Wed, Feb 11th 2009 ] - Market Wire
Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25
[ Wed, Feb 11th 2009 ] - Market Wire
Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"
[ Wed, Feb 11th 2009 ] - Market Wire
Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment
[ Wed, Feb 11th 2009 ] - Market Wire
Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera
[ Wed, Feb 11th 2009 ] - Market Wire
Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc
[ Wed, Feb 11th 2009 ] - Market Wire
POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results
[ Wed, Feb 11th 2009 ] - Market Wire
Salix Pharmaceuticals to Present at Roth Conference
[ Wed, Feb 11th 2009 ] - Market Wire
Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results
[ Wed, Feb 11th 2009 ] - Market Wire
Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350
[ Wed, Feb 11th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough
[ Wed, Feb 11th 2009 ] - Market Wire
Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent
Tue, February 10, 2009
[ Tue, Feb 10th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical
[ Tue, Feb 10th 2009 ] - Market Wire
Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors
[ Tue, Feb 10th 2009 ] - Market Wire
Tenet Announces Definitive Agreement to Sell USC University Hospital
[ Tue, Feb 10th 2009 ] - Market Wire
NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008
[ Tue, Feb 10th 2009 ] - Market Wire
Enzon Announces IND Acceptance for Its Survivin Antagonist
[ Tue, Feb 10th 2009 ] - Market Wire
Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference
[ Tue, Feb 10th 2009 ] - Market Wire
Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace
[ Tue, Feb 10th 2009 ] - Market Wire
PPD to Receive Milestone Payments for First Regul .. Dapoxetine) in Finland and Sweden for Treatment o
[ Tue, Feb 10th 2009 ] - Market Wire
Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics
[ Tue, Feb 10th 2009 ] - Market Wire
Quidel to Hold 2008 Fourth Quarter and Year-End F .. cial Results Conference Call on February 25, 2009
[ Tue, Feb 10th 2009 ] - Market Wire
Progenics Selects Subcutaneous Form of PRO 140, a .. vel HIV Antibody Therapy, for Further Development
[ Tue, Feb 10th 2009 ] - Market Wire
Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study
[ Tue, Feb 10th 2009 ] - Market Wire
Curis Reports Fourth Quarter and Year-End 2008 Financial Results
[ Tue, Feb 10th 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System
[ Tue, Feb 10th 2009 ] - Market Wire
Inspire Elects Alan F. Holmer to Board of Directors
[ Tue, Feb 10th 2009 ] - Market Wire
VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction
[ Tue, Feb 10th 2009 ] - Market Wire
Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference
[ Tue, Feb 10th 2009 ] - Market Wire
Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing
[ Tue, Feb 10th 2009 ] - Market Wire
Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications
[ Tue, Feb 10th 2009 ] - Market Wire
Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.
Mon, February 9, 2009
[ Mon, Feb 09th 2009 ] - Market Wire
UnitedHealthcare, IBM, and Arizona Physicians to .. ndbreaking Patient-Centered Healthcare Initiative
[ Mon, Feb 09th 2009 ] - Market Wire
Clinical Data Announces Third Quarter Fiscal 2009 Financial Results
[ Mon, Feb 09th 2009 ] - Market Wire
Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board
[ Mon, Feb 09th 2009 ] - Market Wire
Forbes Medi-Tech Inc.: Leading Healthy Lifestyle .. y Proven Benefits of Forbes Medi-Tech's Cholester
[ Mon, Feb 09th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia
[ Mon, Feb 09th 2009 ] - Market Wire
Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv
[ Mon, Feb 09th 2009 ] - Market Wire
Genta Incorporated to Release Fourth Quarter Financial Results and Host Conference Call
[ Mon, Feb 09th 2009 ] - Market Wire
Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449
[ Mon, Feb 09th 2009 ] - Market Wire
Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18
[ Mon, Feb 09th 2009 ] - Market Wire
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease
[ Mon, Feb 09th 2009 ] - Market Wire
Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call
[ Mon, Feb 09th 2009 ] - Market Wire
UnitedHealth Group Awarded LEED® Green Building Certification
[ Mon, Feb 09th 2009 ] - Market Wire
Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research
[ Mon, Feb 09th 2009 ] - Market Wire
Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call
[ Mon, Feb 09th 2009 ] - Market Wire
Compugen Appoints Dov Hershberg Chairman of the Board
[ Mon, Feb 09th 2009 ] - Market Wire
Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies
[ Mon, Feb 09th 2009 ] - Market Wire
Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine
[ Mon, Feb 09th 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009
[ Mon, Feb 09th 2009 ] - Market Wire
EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status
[ Mon, Feb 09th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas
Sun, February 8, 2009
[ Sun, Feb 08th 2009 ] - Market Wire
Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco
[ Sun, Feb 08th 2009 ] - Market Wire
MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur
Fri, February 6, 2009
[ Fri, Feb 06th 2009 ] - Market Wire
Celgene Corporation to Present at the 11th Annual BIO CEO Investor Conference
[ Fri, Feb 06th 2009 ] - Market Wire
Proton Laboratories Inc.: Proton Labs to Begin Bottling Functional Water
[ Fri, Feb 06th 2009 ] - Market Wire
Geron to Present at BIO CEO & Investor Conference
[ Fri, Feb 06th 2009 ] - Market Wire
MEDNAX to Present at UBS Global Healthcare Conference
[ Fri, Feb 06th 2009 ] - Market Wire
Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10
[ Fri, Feb 06th 2009 ] - Market Wire
Span-America Announces Termination of Hill-Rom Supply Contract
[ Fri, Feb 06th 2009 ] - Market Wire
CIGNA Announces Appearance at the UBS Global Healthcare Services Conference
[ Fri, Feb 06th 2009 ] - Market Wire
Odyssey Healthcare to Broadcast Its Fourth Quarte .. ear-End 2008 Conference Call Live on the Internet
[ Fri, Feb 06th 2009 ] - Market Wire
LifePoint Hospitals to Broadcast Its Fourth Quart .. ear-End 2008 Conference Call Live on the Internet
[ Fri, Feb 06th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference
[ Fri, Feb 06th 2009 ] - Market Wire
Advanced Medical Optics, Inc. Gives Notice of Ant .. nd Merger to Holders of Convertible Senior Subord
[ Fri, Feb 06th 2009 ] - Market Wire
Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results
[ Fri, Feb 06th 2009 ] - Market Wire
Medtronic Completes Acquisition of Ablation Frontiers
[ Fri, Feb 06th 2009 ] - Market Wire
Ligand Enters into Screening Agreement with Trevena
[ Fri, Feb 06th 2009 ] - Market Wire
Biogen Idec Receives Shareholder Proposal
[ Fri, Feb 06th 2009 ] - Market Wire
Health Management Associates, Inc. Announces Four .. ear-End 2008 Earnings Conference Call and Webcast
[ Fri, Feb 06th 2009 ] - Market Wire
The Genome Center at Washington University Scales-Up on Illumina Sequencers
Thu, February 5, 2009
[ Thu, Feb 05th 2009 ] - Market Wire
Aetna Awarded $150,000 to Northern California Nonprofits in 2008
[ Thu, Feb 05th 2009 ] - Market Wire
FORTIS: Fortis publishes explanatory document on voting at General Meeting
[ Thu, Feb 05th 2009 ] - Market Wire
SCOR: Prestigious Redmayne report recognises SCOR .. d Protection reinsurance in the United Kingdom an
[ Thu, Feb 05th 2009 ] - Market Wire
Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009
[ Thu, Feb 05th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation Announces Fourth Quarter and Full Year 2008 Results
[ Thu, Feb 05th 2009 ] - Market Wire
Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement
[ Thu, Feb 05th 2009 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present At BIO CEO and Investor Conference and ISSWSH Conference
[ Thu, Feb 05th 2009 ] - Market Wire
Progen-Avexa Merger Notice of Meeting and Independent Expert Report
[ Thu, Feb 05th 2009 ] - Market Wire
GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea
[ Thu, Feb 05th 2009 ] - Market Wire
Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital
[ Thu, Feb 05th 2009 ] - Market Wire
StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference
[ Thu, Feb 05th 2009 ] - Market Wire
Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market
[ Thu, Feb 05th 2009 ] - Market Wire
GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast
[ Thu, Feb 05th 2009 ] - Market Wire
BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B
[ Thu, Feb 05th 2009 ] - Market Wire
Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing
[ Thu, Feb 05th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference
[ Thu, Feb 05th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean
[ Thu, Feb 05th 2009 ] - Market Wire
Illumina Presents Development Roadmap for Scaling its Genome Analyzer
[ Thu, Feb 05th 2009 ] - Market Wire
Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference
Wed, February 4, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn
[ Wed, Feb 04th 2009 ] - Market Wire
NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares
[ Wed, Feb 04th 2009 ] - Market Wire
Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of
[ Wed, Feb 04th 2009 ] - Market Wire
Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry
[ Wed, Feb 04th 2009 ] - Market Wire
Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices
[ Wed, Feb 04th 2009 ] - Market Wire
Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,
[ Wed, Feb 04th 2009 ] - Market Wire
Conceptus® to Present at the ROTH 21st Annual OC Growth Stock Conference
[ Wed, Feb 04th 2009 ] - Market Wire
Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3
[ Wed, Feb 04th 2009 ] - Market Wire
Progenics Appoints Peter J. Crowley as Independent Board Member
[ Wed, Feb 04th 2009 ] - Market Wire
UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards
[ Wed, Feb 04th 2009 ] - Market Wire
EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening
[ Wed, Feb 04th 2009 ] - Market Wire
Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System
[ Wed, Feb 04th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf
[ Wed, Feb 04th 2009 ] - Market Wire
MEDNAX, Inc. Acquires Neonatal Practice
[ Wed, Feb 04th 2009 ] - Market Wire
Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009
[ Wed, Feb 04th 2009 ] - Market Wire
Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11
[ Wed, Feb 04th 2009 ] - Market Wire
Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures
Tue, February 3, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
[ Tue, Feb 03rd 2009 ] - Market Wire
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development
[ Tue, Feb 03rd 2009 ] - Market Wire
Affymax to Present at BIO CEO and Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
[ Tue, Feb 03rd 2009 ] - Market Wire
PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009
[ Tue, Feb 03rd 2009 ] - Market Wire
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
[ Tue, Feb 03rd 2009 ] - Market Wire
Amarin to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.
[ Tue, Feb 03rd 2009 ] - Market Wire
Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Amedisys Acquires Two Home Health Agencies in Arizona
[ Tue, Feb 03rd 2009 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.
[ Tue, Feb 03rd 2009 ] - Market Wire
Inspire Announces Webcast of Presentation at BIO CEO Conference
[ Tue, Feb 03rd 2009 ] - Market Wire
Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement
[ Tue, Feb 03rd 2009 ] - Market Wire
Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19
Mon, February 2, 2009
[ Mon, Feb 02nd 2009 ] - Market Wire
Kindred Healthcare to Present at the UBS Global Healthcare Services Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
LHC Group and Ochsner Health System Complete Home Health Joint Venture
[ Mon, Feb 02nd 2009 ] - Market Wire
Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in
[ Mon, Feb 02nd 2009 ] - Market Wire
Ligand Announces Phase IIb Results With DARA
[ Mon, Feb 02nd 2009 ] - Market Wire
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
[ Mon, Feb 02nd 2009 ] - Market Wire
Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call
[ Mon, Feb 02nd 2009 ] - Market Wire
Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia
[ Mon, Feb 02nd 2009 ] - Market Wire
ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma
[ Mon, Feb 02nd 2009 ] - Market Wire
Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital
[ Mon, Feb 02nd 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)
[ Mon, Feb 02nd 2009 ] - Market Wire
Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®
[ Mon, Feb 02nd 2009 ] - Market Wire
Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment
[ Mon, Feb 02nd 2009 ] - Market Wire
Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S
[ Mon, Feb 02nd 2009 ] - Market Wire
LifePoint Hospitals Acquires Rockdale Medical Center
[ Mon, Feb 02nd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference
[ Mon, Feb 02nd 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in
[ Mon, Feb 02nd 2009 ] - Market Wire
ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results
Sun, February 1, 2009
[ Sun, Feb 01st 2009 ] - Market Wire
FORTIS: Fortis holding announcement
Sat, January 31, 2009
[ Sat, Jan 31st 2009 ] - Market Wire
FORTIS: Fortis holding publishes addendum to shareholder circular
[ Sat, Jan 31st 2009 ] - Market Wire
Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util
[ Sat, Jan 31st 2009 ] - Market Wire
REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification
[ Fri, Jan 30th 2009 ] - Market Wire
Teva Announces Approval of Generic Risperdal® Oral Solution
[ Fri, Jan 30th 2009 ] - Market Wire
ZOLL Announces Filing of Patent Infringement Suit .. Alsius Corporation and Alsius Medical Corporation
[ Fri, Jan 30th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer
[ Fri, Jan 30th 2009 ] - Market Wire
First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence
[ Fri, Jan 30th 2009 ] - Market Wire
DexCom Announces Pricing of Public Offering of Common Stock
[ Fri, Jan 30th 2009 ] - Market Wire
Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference
[ Fri, Jan 30th 2009 ] - Market Wire
GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry
[ Fri, Jan 30th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
[ Fri, Jan 30th 2009 ] - Market Wire
St. Jude Medical Announces 2009 Annual Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
SonoSite Introduces Powerful New Turbo Technology for S Series"
[ Fri, Jan 30th 2009 ] - Market Wire
GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame
[ Fri, Jan 30th 2009 ] - Market Wire
Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference
[ Fri, Jan 30th 2009 ] - Market Wire
Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time
[ Fri, Jan 30th 2009 ] - Market Wire
REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us
[ Fri, Jan 30th 2009 ] - Market Wire
Santarus Submits New Drug Application for ZEGERID Tablet Product
Thu, January 29, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
Universal Health Services, Inc. Announces Fourth .. ll Year 2008 Earnings Release and Conference Call
[ Thu, Jan 29th 2009 ] - Market Wire
Theravance, Inc.: Theravance to Report Fourth Qua .. Year 2008 Financial Results on February 12, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
EXACT Sciences Regains NASDAQ Compliance
[ Thu, Jan 29th 2009 ] - Market Wire
CompCare Acquires Core Corporate Consulting Group, Inc.
[ Thu, Jan 29th 2009 ] - Market Wire
Proteonomix, Inc: Proteonomix, Inc. (PROT) Announ .. Dubrow, M.D., a Noted Plastic Surgeon and Partici
[ Thu, Jan 29th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Elects Alexander Casdin to Board of Directors
[ Thu, Jan 29th 2009 ] - Market Wire
Synergetics USA, Inc. Appoints David M. Hable as President & Chief Executive Officer
[ Thu, Jan 29th 2009 ] - Market Wire
XenoPort to Release Fourth Quarter Financial Results on February 12, 2009
[ Thu, Jan 29th 2009 ] - Market Wire
Fraunhofer USA to use iBioPharma?s Technology for Pandemic Flu Vaccine Research
[ Thu, Jan 29th 2009 ] - Market Wire
BioSphere Medical Schedules Fourth Quarter 2008 Financial Results Conference Call February 12
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Educates Women about Role of Folic Acid in Preventing Premature Birth
[ Thu, Jan 29th 2009 ] - Market Wire
Harte Gold Corp.: Harte Clarifies Affairs
[ Thu, Jan 29th 2009 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Television Show to Air in Chicago
[ Thu, Jan 29th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast
[ Thu, Jan 29th 2009 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5
[ Thu, Jan 29th 2009 ] - Market Wire
Oscient Pharmaceuticals Extends Maturity of its Privately Placed 5% Convertible Promissory Notes
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $590,000 to Non-Profits in Pennsylvania
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $125,000 to North Carolina Non-Profits
[ Thu, Jan 29th 2009 ] - Market Wire
Aetna Awarded $725,000 to Georgia Non-Profits

Enzon to Present at 11th Annual BIO CEO & Investor Conference


//health-fitness.news-articles.net/content/2009/ .. -at-11th-annual-bio-ceo-investor-conference.html
Published in Health and Fitness on , Last Modified on 2009-02-04 15:26:14 by Market Wire   Print publication without navigation


BRIDGEWATER, N.J.--([ BUSINESS WIRE ])--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that Jeffrey H. Buchalter, Enzon's chairman and chief executive officer, will present at the 11th Annual BIO CEO & Investor Conference at 3:15 p.m. Eastern Time (ET) on Tuesday, February 10, 2009 at the Waldorf Astoria Hotel in New York City.

About Enzon

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development, manufacturing, commercialization of important medicines for patients with cancer and other life-threatening conditions. Enzon has a portfolio of four marketed products, Oncaspar®, DepoCyt®, Abelcet® and Adagen®. The Company's drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform used to create product candidates with benefits such as reduced dosing frequency and less toxicity. Enzon's PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. Enzon also engages in contract manufacturing for several pharmaceutical companies to broaden the Company's revenue base. Further information about Enzon and this press release can be found on the Company's web site at [ www.enzon.com ].


Publication Contributing Sources